Interface Selection for Adaptive Servo Ventilation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment with ASV, will be randomized between two groups. In the first group, patients will use a nasal interface during the first night and an oronasal interface during the second night. In the second group, patients will use an oronasal mask first and a nasal mask during the second night. The results of this trial will have major impact on future clinical practice as it would deliver prediction rules to choose the correct interface immediately.

Eligibility criteria

Qualifiers

Patients with central sleep apnea, not responding to treatment with CPAP

Indication for treatment with ASV

Disqualifiers

Patients < 18 years old

Trial design

Treatments tested in this trial

  • Switch from oronasal to nasal mask during ASV treatment
  • Switch from nasal to oronasal mask during ASV treatment

Treatment groups

15 Participants
are divided into 2 treatment groups